At Pandemic’s Two Year Milestone: More Investment in the World’s Nurses is Needed – Now 11/03/2022 Howard Catton The applause has long ceased – while the ongoing pressures of the pandemic have left long-term scars on the physical, moral and mental health of the world’s nurses. Two years into the COVID-19 pandemic, governments need to offer better solutions. On 11 March 2020, the World Health Organization (WHO) declared a pandemic, and the world […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
No One Is Safe Until Everyone Is Safe? Reporting a Polio Outbreak at Snail’s Pace 22/02/2022 Elaine Ruth Fletcher & Rahul Basharat Rajput ISLAMABAD – The timing couldn’t have been worse. On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> Posts navigation Older postsNewer posts